Logout 
live
Ebola
Ebola Spreading Rapidly, Uganda Issues Alert, Ask People To Remain Vigilent
Ebola is an infectious and extremely fatal disease that is marked by a sudden rise in body temperature, and severe internal bleeding.
Ebola is an infectious and extremely fatal disease that is marked by a sudden rise in body temperature, and severe internal bleeding.
ZMapp And Remdesivir should not be used to treat Ebola virus disease, the World Health Organization (WHO) said in its new guideline.
The Ebola virus which is spreading again in the regions of Africa is an infection that can kill the infected individuals within 6 to 16 days after showing symptoms.
The largest outbreak to date took place in West Africa between March 2014 and June 2016, affecting primarily Guinea, Liberia, and Sierra Leone. Over 28,000 cases were recorded.
The patients who have tested for the virus ad showed symptoms of hemorrhagic fever. Meanwhile, all individuals who came in contact with the infected people have been put under isolation, officials reported.
A new quicker device has been developed by a team of researchers with members from the U.S., Senegal, and Guinea, in cooperation with Becton, Dickinson and Company (BD), for a quicker detection of the Ebola virus.
The ministry confirmed about the latest cases near the town of Mangina in Congo's North Kivu province. However, the disease has not touched the red zone.
Ebola virus spread through direct contact with body fluids and it can cause hemorrhagic fever, vomiting and diarrhoea.
Researchers have found that an enzyme could help prevent the deadly virus from spreading.
Detection of Ebola virus RNA in the semen of men who had previously had a negative test of their semen in some cases.
This is also a very cost-effective treatment that can be used in low-income countries.
Some of the final cases of Ebola in Sierra Leone were transmitted via unconventional routes, such as semen and breast milk, shows an analysis of the tail-end of the epidemic.
These results stress the importance of monitoring survivors in order to prevent the risks of new epidemic outbreaks.
In an important advancement towards an effective treatment against the deadly Ebola virus disease (EVD), researchers have found that a single monoclonal antibody isolated from a human survivor completely protects monkeys from lethal infection with the virus.
The device could be particularly useful to monitor endemic, epidemic and pandemic disease outbreaks in resource-limited developing countries that need portable diagnostic equipment that functions outside the hospital.
For the first time since the devastating outbreak began, all known chains of transmission of Ebola in West Africa have been stopped and no new cases have been reported since the end of November, said a statement by Ban's spokesman.
A recent research has engineered the first antibodies that can potently neutralise the two deadliest strains of the virus that causes Ebola hemorrhagic fever.
Ebola strikes again, toll reaches 11,220 in West Africa
Ebola is an infectious and extremely fatal disease that is marked by a sudden rise in body temperature, and severe internal bleeding.
ZMapp And Remdesivir should not be used to treat Ebola virus disease, the World Health Organization (WHO) said in its new guideline.
The Ebola virus which is spreading again in the regions of Africa is an infection that can kill the infected individuals within 6 to 16 days after showing symptoms.
The largest outbreak to date took place in West Africa between March 2014 and June 2016, affecting primarily Guinea, Liberia, and Sierra Leone. Over 28,000 cases were recorded.
The patients who have tested for the virus ad showed symptoms of hemorrhagic fever. Meanwhile, all individuals who came in contact with the infected people have been put under isolation, officials reported.
A new quicker device has been developed by a team of researchers with members from the U.S., Senegal, and Guinea, in cooperation with Becton, Dickinson and Company (BD), for a quicker detection of the Ebola virus.
The ministry confirmed about the latest cases near the town of Mangina in Congo's North Kivu province. However, the disease has not touched the red zone.
Ebola virus spread through direct contact with body fluids and it can cause hemorrhagic fever, vomiting and diarrhoea.
Researchers have found that an enzyme could help prevent the deadly virus from spreading.
Detection of Ebola virus RNA in the semen of men who had previously had a negative test of their semen in some cases.
This is also a very cost-effective treatment that can be used in low-income countries.
Some of the final cases of Ebola in Sierra Leone were transmitted via unconventional routes, such as semen and breast milk, shows an analysis of the tail-end of the epidemic.
These results stress the importance of monitoring survivors in order to prevent the risks of new epidemic outbreaks.
In an important advancement towards an effective treatment against the deadly Ebola virus disease (EVD), researchers have found that a single monoclonal antibody isolated from a human survivor completely protects monkeys from lethal infection with the virus.
The device could be particularly useful to monitor endemic, epidemic and pandemic disease outbreaks in resource-limited developing countries that need portable diagnostic equipment that functions outside the hospital.
For the first time since the devastating outbreak began, all known chains of transmission of Ebola in West Africa have been stopped and no new cases have been reported since the end of November, said a statement by Ban's spokesman.
A recent research has engineered the first antibodies that can potently neutralise the two deadliest strains of the virus that causes Ebola hemorrhagic fever.
Ebola strikes again, toll reaches 11,220 in West Africa
